Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Pharma
Asahi Kasei makes good on AiCurus buyout with new FDA nod
Roughly half a year after the close of its deal to acquire Bayer spinout AiCurus, Asahi Kasei’s $920 million bet has paid off with an FDA nod.
Fraiser Kansteiner
Oct 12, 2026 10:28am
Teva bags long-sought reformulated olanzapine schizophrenia nod
Oct 9, 2026 9:56am
Novartis expands Rhapsido's growing reach in chronic hives
Oct 7, 2026 2:27pm
Novo cites production site corrections amid hemophilia FDA delay
Oct 5, 2026 7:15am
Litfulo and tilrekimig data bolster Pfizer's immunology plans
Oct 2, 2026 11:15am
Vanda eyes expansion prospect for Hetlioz outside jet lag
Sep 30, 2026 11:13am
